Bain Capital Life Sciences Investors, LLC bought $40.0M of NAMS

bought $40.00m of NAMS

1,632,653 shares @ $24.50

New position

2nd largest trade (out of 34)

Large TradeCluster Buy

Trade made by a 10% owner

Part of a cluster of 10 transactions by 10 insiders

Unscheduled trade

38% win rate · -14.8% median edge vs SPY (8 trades, 90-day · small sample)

Price 27% above 200-day moving average

NAMSNewAmsterdam Pharma Co N.V.

HealthcareBiotechnology

1D0.00%

1W+4.78%

1M+6.61%

3M—

6M—

1Y—

Recent insider activity at NAMS